Structure

Physi-Chem Properties

Molecular Weight:  240.04
Volume:  239.1
LogP:  3.318
LogD:  2.243
LogS:  -4.099
# Rotatable Bonds:  0
TPSA:  74.6
# H-Bond Aceptor:  4
# H-Bond Donor:  2
# Rings:  3
# Heavy Atoms:  4

MedChem Properties

QED Drug-Likeness Score:  0.692
Synthetic Accessibility Score:  2.361
Fsp3:  0.0
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.944
MDCK Permeability:  1.4165588254400063e-05
Pgp-inhibitor:  0.005
Pgp-substrate:  0.0
Human Intestinal Absorption (HIA):  0.167
20% Bioavailability (F20%):  0.005
30% Bioavailability (F30%):  0.968

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.045
Plasma Protein Binding (PPB):  99.82230377197266%
Volume Distribution (VD):  0.359
Pgp-substrate:  1.2660423517227173%

ADMET: Metabolism

CYP1A2-inhibitor:  0.979
CYP1A2-substrate:  0.119
CYP2C19-inhibitor:  0.15
CYP2C19-substrate:  0.09
CYP2C9-inhibitor:  0.489
CYP2C9-substrate:  0.468
CYP2D6-inhibitor:  0.605
CYP2D6-substrate:  0.27
CYP3A4-inhibitor:  0.455
CYP3A4-substrate:  0.112

ADMET: Excretion

Clearance (CL):  4.683
Half-life (T1/2):  0.433

ADMET: Toxicity

hERG Blockers:  0.01
Human Hepatotoxicity (H-HT):  0.413
Drug-inuced Liver Injury (DILI):  0.938
AMES Toxicity:  0.844
Rat Oral Acute Toxicity:  0.774
Maximum Recommended Daily Dose:  0.887
Skin Sensitization:  0.922
Carcinogencity:  0.762
Eye Corrosion:  0.01
Eye Irritation:  0.96
Respiratory Toxicity:  0.433

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC96915

Natural Product ID:  NPC96915
Common Name*:   Quinizarin
IUPAC Name:   1,4-dihydroxyanthracene-9,10-dione
Synonyms:   1,4 Dihydroxy-Anthraquinone; 1,4-Dihydroxy-Anthraquinone; 1,4-Dihydroxyanthraquinone; Quinizarin
Standard InCHIKey:  GUEIZVNYDFNHJU-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C14H8O4/c15-9-5-6-10(16)12-11(9)13(17)7-3-1-2-4-8(7)14(12)18/h1-6,15-16H
SMILES:  c1ccc2c(c1)C(=O)c1c(ccc(c1C2=O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL17594
PubChem CID:   6688
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0002448] Benzenoids
      • [CHEMONTID:0000018] Anthracenes
        • [CHEMONTID:0000151] Anthraquinones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO11391 Polygonum cuspidatum Species Polygonaceae Eukaryota n.a. n.a. n.a. PMID[11076555]
NPO11391 Polygonum cuspidatum Species Polygonaceae Eukaryota Roots n.a. n.a. PMID[11459643]
NPO11391 Polygonum cuspidatum Species Polygonaceae Eukaryota n.a. n.a. n.a. PMID[1517743]
NPO8921 Senna obtusifolia Species Fabaceae Eukaryota Seeds n.a. n.a. PMID[2213033]
NPO11391 Polygonum cuspidatum Species Polygonaceae Eukaryota n.a. n.a. n.a. PMID[8277318]
NPO29836 Cassia obtusifolia Species Fabaceae Eukaryota n.a. seed n.a. PMID[9810700]
NPO29836 Cassia obtusifolia Species Fabaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO11391 Polygonum cuspidatum Species Polygonaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO11391 Polygonum cuspidatum Species Polygonaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO8921 Senna obtusifolia Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO29836 Cassia obtusifolia Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO11391 Polygonum cuspidatum Species Polygonaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO11391 Polygonum cuspidatum Species Polygonaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO8921 Senna obtusifolia Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO11391 Polygonum cuspidatum Species Polygonaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO8921 Senna obtusifolia Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT152 Individual Protein Nuclear factor erythroid 2-related factor 2 Homo sapiens Potency n.a. 2730.6 nM PubChem BioAssay data set
NPT106 Individual Protein Peroxisome proliferator-activated receptor delta Homo sapiens Potency n.a. 27535.7 nM PubChem BioAssay data set
NPT153 Individual Protein Androgen Receptor Homo sapiens Potency n.a. 30895.6 nM PubChem BioAssay data set
NPT319 Cell Line B16 Mus musculus IC50 > 30.0 ug.mL-1 PMID[514057]
NPT393 Cell Line HCT-116 Homo sapiens IC50 > 30.0 ug.mL-1 PMID[514057]
NPT762 Cell Line A-431 Homo sapiens IC50 > 30.0 ug.mL-1 PMID[514057]
NPT80 Cell Line Raji Homo sapiens Activity > 80.0 % PMID[514062]
NPT80 Cell Line Raji Homo sapiens Activity = 70.0 % PMID[514062]
NPT3266 Individual Protein Casein kinase I delta Homo sapiens IC50 > 40000.0 nM PMID[514063]
NPT1684 Individual Protein Casein kinase I gamma 1 Homo sapiens IC50 > 40000.0 nM PMID[514063]
NPT3168 Individual Protein Casein kinase I alpha Homo sapiens IC50 > 40000.0 nM PMID[514063]
NPT51 Individual Protein Microtubule-associated protein tau Homo sapiens Potency = 14125.4 nM PMID[514065]
NPT53 Individual Protein 4'-phosphopantetheinyl transferase ffp Bacillus subtilis Potency = 79432.8 nM PMID[514065]
NPT51 Individual Protein Microtubule-associated protein tau Homo sapiens Potency = 1995.3 nM PMID[514065]
NPT3022 Individual Protein Thioredoxin reductase 2, mitochondrial Rattus norvegicus IC50 > 200000.0 nM PMID[514066]
NPT198 Individual Protein Vitamin D receptor Homo sapiens Potency n.a. 44668.4 nM PMID[514065]
NPT368 Cell Line SN12C Homo sapiens GI50 n.a. 100000.0 nM PMID[514068]
NPT369 Cell Line ACHN Homo sapiens GI50 n.a. 100000.0 nM PMID[514068]
NPT370 Cell Line NCI-H23 Homo sapiens GI50 n.a. 100000.0 nM PMID[514068]
NPT371 Cell Line UO-31 Homo sapiens GI50 n.a. 59020.11 nM PMID[514068]
NPT116 Cell Line HL-60 Homo sapiens GI50 n.a. 100000.0 nM PMID[514068]
NPT372 Cell Line HOP-92 Homo sapiens GI50 n.a. 100000.0 nM PMID[514068]
NPT374 Cell Line SF-539 Homo sapiens GI50 n.a. 100000.0 nM PMID[514068]
NPT373 Cell Line SK-MEL-5 Homo sapiens GI50 n.a. 63095.73 nM PMID[514068]
NPT375 Cell Line Malme-3M Homo sapiens GI50 n.a. 100000.0 nM PMID[514068]
NPT376 Cell Line A498 Homo sapiens GI50 n.a. 100000.0 nM PMID[514068]
NPT111 Cell Line K562 Homo sapiens GI50 n.a. 100000.0 nM PMID[514068]
NPT377 Cell Line OVCAR-3 Homo sapiens GI50 n.a. 29241.52 nM PMID[514068]
NPT112 Cell Line MOLT-4 Homo sapiens GI50 n.a. 51999.6 nM PMID[514068]
NPT379 Cell Line HOP-62 Homo sapiens GI50 n.a. 100000.0 nM PMID[514068]
NPT380 Cell Line U-251 Homo sapiens GI50 n.a. 100000.0 nM PMID[514068]
NPT381 Cell Line OVCAR-8 Homo sapiens GI50 n.a. 100000.0 nM PMID[514068]
NPT382 Cell Line OVCAR-5 Homo sapiens GI50 n.a. 100000.0 nM PMID[514068]
NPT383 Cell Line SNB-19 Homo sapiens GI50 n.a. 100000.0 nM PMID[514068]
NPT572 Cell Line DMS-273 Homo sapiens GI50 n.a. 100000.0 nM PMID[514068]
NPT384 Cell Line TK-10 Homo sapiens GI50 n.a. 100000.0 nM PMID[514068]
NPT323 Cell Line SW-620 Homo sapiens GI50 n.a. 93756.2 nM PMID[514068]
NPT573 Cell Line M19-MEL Homo sapiens GI50 n.a. 21827.3 nM PMID[514068]
NPT455 Cell Line NCI-H522 Homo sapiens GI50 n.a. 100000.0 nM PMID[514068]
NPT386 Cell Line KM12 Homo sapiens GI50 n.a. 60534.09 nM PMID[514068]
NPT387 Cell Line M14 Homo sapiens GI50 n.a. 100000.0 nM PMID[514068]
NPT574 Cell Line XF498 Homo sapiens GI50 n.a. 100000.0 nM PMID[514068]
NPT388 Cell Line NCI-H322M Homo sapiens GI50 n.a. 100000.0 nM PMID[514068]
NPT389 Cell Line RPMI-8226 Homo sapiens GI50 n.a. 90991.33 nM PMID[514068]
NPT456 Cell Line OVCAR-4 Homo sapiens GI50 n.a. 100000.0 nM PMID[514068]
NPT390 Cell Line LOX IMVI Homo sapiens GI50 n.a. 100000.0 nM PMID[514068]
NPT147 Cell Line SK-MEL-2 Homo sapiens GI50 n.a. 79799.47 nM PMID[514068]
NPT391 Cell Line HCC 2998 Homo sapiens GI50 n.a. 81096.11 nM PMID[514068]
NPT81 Cell Line A549 Homo sapiens GI50 n.a. 81283.05 nM PMID[514068]
NPT392 Cell Line SNB-75 Homo sapiens GI50 n.a. 100000.0 nM PMID[514068]
NPT393 Cell Line HCT-116 Homo sapiens GI50 n.a. 100000.0 nM PMID[514068]
NPT148 Cell Line HCT-15 Homo sapiens GI50 n.a. 100000.0 nM PMID[514068]
NPT395 Cell Line SF-268 Homo sapiens GI50 n.a. 100000.0 nM PMID[514068]
NPT394 Cell Line EKVX Homo sapiens GI50 n.a. 58748.94 nM PMID[514068]
NPT731 Cell Line LXFL 529 Homo sapiens GI50 n.a. 100000.0 nM PMID[514068]
NPT576 Cell Line DMS-114 Homo sapiens GI50 n.a. 100000.0 nM PMID[514068]
NPT146 Cell Line SK-OV-3 Homo sapiens GI50 n.a. 100000.0 nM PMID[514068]
NPT397 Cell Line NCI-H460 Homo sapiens GI50 n.a. 40831.94 nM PMID[514068]
NPT398 Cell Line UACC-62 Homo sapiens GI50 n.a. 100000.0 nM PMID[514068]
NPT308 Cell Line CAKI-1 Homo sapiens GI50 n.a. 100000.0 nM PMID[514068]
NPT458 Cell Line IGROV-1 Homo sapiens GI50 n.a. 100000.0 nM PMID[514068]
NPT399 Cell Line SF-295 Homo sapiens GI50 n.a. 100000.0 nM PMID[514068]
NPT401 Cell Line 786-0 Homo sapiens GI50 n.a. 100000.0 nM PMID[514068]
NPT577 Cell Line RXF 631 Homo sapiens GI50 n.a. 100000.0 nM PMID[514068]
NPT578 Cell Line SNB-78 Homo sapiens GI50 n.a. 100000.0 nM PMID[514068]
NPT403 Cell Line UACC-257 Homo sapiens GI50 n.a. 100000.0 nM PMID[514068]
NPT404 Cell Line CCRF-CEM Homo sapiens GI50 n.a. 100000.0 nM PMID[514068]
NPT579 Cell Line DLD-1 Homo sapiens GI50 n.a. 61944.11 nM PMID[514068]
NPT139 Cell Line HT-29 Homo sapiens GI50 n.a. 45289.76 nM PMID[514068]
NPT170 Cell Line SK-MEL-28 Homo sapiens GI50 n.a. 100000.0 nM PMID[514068]
NPT407 Cell Line COLO 205 Homo sapiens GI50 n.a. 100000.0 nM PMID[514068]
NPT406 Cell Line RXF 393 Homo sapiens GI50 n.a. 100000.0 nM PMID[514068]
NPT323 Cell Line SW-620 Homo sapiens Activity = 21.1 % PMID[514071]
NPT65 Cell Line HepG2 Homo sapiens Activity = 5.6 % PMID[514071]
NPT2 Others Unspecified Potency n.a. 68589.6 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 1096.2 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 61644.8 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 19331.2 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 3063.8 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 7760.6 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 7695.9 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 6859 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 19493.8 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 54482.7 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 24541.2 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 15.5 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 38570.8 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 21689.9 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 6113.1 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 10870.7 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 21872.4 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 48557.7 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 27306 nM PubChem BioAssay data set
NPT544 Protein Family Estrogen receptor Homo sapiens Control = 109.0 % PMID[514058]
NPT544 Protein Family Estrogen receptor Homo sapiens Control = 106.6 % PMID[514058]
NPT544 Protein Family Estrogen receptor Homo sapiens Control = 104.1 % PMID[514058]
NPT138 Organism Brugia malayi Brugia malayi Mortality = 10.0 % PMID[514059]
NPT878 Organism Streptococcus mutans Streptococcus mutans MIC = 250.0 ug.mL-1 PMID[514060]
NPT878 Organism Streptococcus mutans Streptococcus mutans Inhibition = 80.0 % PMID[514060]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Activity > 0.25 mg/ml PMID[514061]
NPT2 Others Unspecified Inhibition = 100.0 % PMID[514062]
NPT2 Others Unspecified Inhibition = 89.5 % PMID[514062]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Activity = 833.0 % PMID[514064]
NPT35 Others n.a. Activity = 205.0 % PMID[514064]
NPT2 Others Unspecified Activity = 30.0 uL PMID[514064]
NPT197 Protein-Protein Interaction Menin/Histone-lysine N-methyltransferase MLL Homo sapiens Potency = 12589.3 nM PMID[514065]
NPT2 Others Unspecified Potency = 2818.4 nM PMID[514065]
NPT7 Individual Protein Thioredoxin reductase 1, cytoplasmic Rattus norvegicus IC50 > 200000.0 nM PMID[514066]
NPT533 Protein-Protein Interaction Runt-related transcription factor 1/Core-binding factor subunit beta Homo sapiens Potency n.a. 12589.3 nM PMID[514065]
NPT901 Individual Protein UDP-glucuronosyltransferase 1-1 Homo sapiens Activity = 17.0 pm/min/mg PMID[514067]
NPT901 Individual Protein UDP-glucuronosyltransferase 1-1 Homo sapiens Activity = 0.0 pm/min/mg PMID[514067]
NPT902 Individual Protein UDP-glucuronosyltransferase 1A4 Homo sapiens Activity = 0.0 pm/min/mg PMID[514067]
NPT702 Individual Protein UDP-glucuronosyltransferase 1-6 Homo sapiens Activity = 0.0 pm/min/mg PMID[514067]
NPT703 Individual Protein UDP-glucuronosyltransferase 1-9 Homo sapiens Activity = 40.0 pm/min/mg PMID[514067]
NPT704 Individual Protein UDP-glucuronosyltransferase 2B15 Homo sapiens Activity = 0.0 pm/min/mg PMID[514067]
NPT317 Uncleic Acid Nucleic Acid Ratio = 5.0 n.a. PMID[514069]
NPT317 Uncleic Acid Nucleic Acid Kb = 3.2 10'7/M PMID[514069]
NPT317 Uncleic Acid Nucleic Acid Kb = 1.66 10'4/M PMID[514069]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Activity = 12.3 % PMID[514071]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Activity = 38.4 % PMID[514071]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Activity = 48.6 % PMID[514071]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 > 10000.0 nM PMID[514071]
NPT320 Protein Family DNA topoisomerase II Homo sapiens IC50 > 200000.0 nM PMID[514072]
NPT21742 CELL-LINE L02 Homo sapiens IC50 > 200000.0 nM PMID[514072]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC96915 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9748 High Similarity NPC375356
0.9664 High Similarity NPC300274
0.9597 High Similarity NPC205992
0.9587 High Similarity NPC103540
0.936 High Similarity NPC136588
0.936 High Similarity NPC199253
0.9355 High Similarity NPC282923
0.935 High Similarity NPC306765
0.9344 High Similarity NPC142956
0.928 High Similarity NPC99731
0.9225 High Similarity NPC155211
0.9225 High Similarity NPC272268
0.9225 High Similarity NPC474813
0.9213 High Similarity NPC70622
0.92 High Similarity NPC48248
0.9194 High Similarity NPC3224
0.9167 High Similarity NPC232178
0.9154 High Similarity NPC245923
0.9141 High Similarity NPC52407
0.9127 High Similarity NPC34414
0.9127 High Similarity NPC146647
0.912 High Similarity NPC471530
0.9091 High Similarity NPC285829
0.9091 High Similarity NPC206778
0.907 High Similarity NPC288089
0.9055 High Similarity NPC31539
0.9055 High Similarity NPC55949
0.9055 High Similarity NPC31799
0.9032 High Similarity NPC310540
0.9032 High Similarity NPC173978
0.9024 High Similarity NPC91478
0.9024 High Similarity NPC307174
0.9008 High Similarity NPC147418
0.8992 High Similarity NPC115458
0.8992 High Similarity NPC225051
0.8992 High Similarity NPC294226
0.8984 High Similarity NPC244699
0.8943 High Similarity NPC120545
0.8923 High Similarity NPC44437
0.8917 High Similarity NPC108288
0.8915 High Similarity NPC242358
0.8915 High Similarity NPC110609
0.8915 High Similarity NPC246693
0.8889 High Similarity NPC1991
0.8889 High Similarity NPC231774
0.8881 High Similarity NPC124365
0.888 High Similarity NPC234890
0.888 High Similarity NPC74507
0.8872 High Similarity NPC143438
0.8864 High Similarity NPC305060
0.8855 High Similarity NPC283088
0.8855 High Similarity NPC80035
0.8846 High Similarity NPC53896
0.8833 High Similarity NPC240163
0.8828 High Similarity NPC278928
0.8788 High Similarity NPC141934
0.8788 High Similarity NPC193358
0.878 High Similarity NPC7151
0.878 High Similarity NPC473662
0.878 High Similarity NPC216297
0.8779 High Similarity NPC50924
0.8769 High Similarity NPC58685
0.875 High Similarity NPC237225
0.875 High Similarity NPC238629
0.873 High Similarity NPC152525
0.873 High Similarity NPC68756
0.8722 High Similarity NPC53206
0.8722 High Similarity NPC53414
0.8712 High Similarity NPC258502
0.8712 High Similarity NPC22222
0.8712 High Similarity NPC281513
0.8712 High Similarity NPC161632
0.871 High Similarity NPC472046
0.8702 High Similarity NPC314048
0.8702 High Similarity NPC171968
0.8692 High Similarity NPC93015
0.8692 High Similarity NPC85342
0.8689 High Similarity NPC269414
0.8678 High Similarity NPC161304
0.8676 High Similarity NPC474300
0.8657 High Similarity NPC13715
0.8657 High Similarity NPC416
0.8657 High Similarity NPC4214
0.8657 High Similarity NPC61398
0.8651 High Similarity NPC477153
0.8647 High Similarity NPC254847
0.8647 High Similarity NPC472308
0.8623 High Similarity NPC471683
0.8615 High Similarity NPC198305
0.8615 High Similarity NPC475741
0.8613 High Similarity NPC476473
0.8607 High Similarity NPC477453
0.8605 High Similarity NPC234175
0.8594 High Similarity NPC227741
0.8594 High Similarity NPC160499
0.8594 High Similarity NPC136342
0.8594 High Similarity NPC51037
0.8594 High Similarity NPC49647
0.8594 High Similarity NPC295202
0.8593 High Similarity NPC190457
0.8593 High Similarity NPC242994
0.8593 High Similarity NPC26924
0.8593 High Similarity NPC1268
0.8593 High Similarity NPC138099
0.8583 High Similarity NPC236189
0.8582 High Similarity NPC471905
0.8571 High Similarity NPC283514
0.8561 High Similarity NPC300540
0.855 High Similarity NPC474517
0.855 High Similarity NPC72669
0.855 High Similarity NPC141549
0.854 High Similarity NPC257644
0.8529 High Similarity NPC181560
0.8529 High Similarity NPC169452
0.8529 High Similarity NPC225243
0.8529 High Similarity NPC315578
0.8529 High Similarity NPC203063
0.8529 High Similarity NPC96421
0.8516 High Similarity NPC131799
0.8496 Intermediate Similarity NPC287604
0.8496 Intermediate Similarity NPC472262
0.8496 Intermediate Similarity NPC161964
0.8492 Intermediate Similarity NPC198336
0.8478 Intermediate Similarity NPC471682
0.8473 Intermediate Similarity NPC278787
0.8473 Intermediate Similarity NPC117609
0.8468 Intermediate Similarity NPC41567
0.8467 Intermediate Similarity NPC187843
0.8467 Intermediate Similarity NPC290550
0.8462 Intermediate Similarity NPC95537
0.8456 Intermediate Similarity NPC216312
0.8456 Intermediate Similarity NPC29771
0.8456 Intermediate Similarity NPC256463
0.8456 Intermediate Similarity NPC471602
0.8456 Intermediate Similarity NPC306835
0.8456 Intermediate Similarity NPC111422
0.8456 Intermediate Similarity NPC476477
0.8456 Intermediate Similarity NPC299405
0.8425 Intermediate Similarity NPC244351
0.8421 Intermediate Similarity NPC267205
0.8417 Intermediate Similarity NPC10764
0.8406 Intermediate Similarity NPC69755
0.8406 Intermediate Similarity NPC73061
0.8406 Intermediate Similarity NPC239136
0.8406 Intermediate Similarity NPC19631
0.8406 Intermediate Similarity NPC193555
0.8394 Intermediate Similarity NPC220496
0.8394 Intermediate Similarity NPC42262
0.8394 Intermediate Similarity NPC241349
0.8394 Intermediate Similarity NPC37992
0.8394 Intermediate Similarity NPC327916
0.8394 Intermediate Similarity NPC147542
0.8394 Intermediate Similarity NPC32749
0.8394 Intermediate Similarity NPC183345
0.8385 Intermediate Similarity NPC45537
0.8382 Intermediate Similarity NPC173980
0.8382 Intermediate Similarity NPC206207
0.8359 Intermediate Similarity NPC275145
0.8359 Intermediate Similarity NPC135062
0.8358 Intermediate Similarity NPC282780
0.8358 Intermediate Similarity NPC166480
0.8346 Intermediate Similarity NPC309430
0.8345 Intermediate Similarity NPC66593
0.8333 Intermediate Similarity NPC108129
0.8333 Intermediate Similarity NPC204045
0.8333 Intermediate Similarity NPC471444
0.8333 Intermediate Similarity NPC7569
0.8333 Intermediate Similarity NPC246638
0.8333 Intermediate Similarity NPC305845
0.8333 Intermediate Similarity NPC257003
0.8333 Intermediate Similarity NPC477275
0.8322 Intermediate Similarity NPC315520
0.8321 Intermediate Similarity NPC767
0.8321 Intermediate Similarity NPC96024
0.8321 Intermediate Similarity NPC165257
0.8321 Intermediate Similarity NPC114620
0.8321 Intermediate Similarity NPC103337
0.8321 Intermediate Similarity NPC247250
0.8319 Intermediate Similarity NPC141523
0.8308 Intermediate Similarity NPC8745
0.8306 Intermediate Similarity NPC312800
0.8298 Intermediate Similarity NPC147250
0.8293 Intermediate Similarity NPC163154
0.8286 Intermediate Similarity NPC244691
0.8286 Intermediate Similarity NPC79627
0.8286 Intermediate Similarity NPC193703
0.8286 Intermediate Similarity NPC21599
0.8286 Intermediate Similarity NPC471906
0.8273 Intermediate Similarity NPC469520
0.8273 Intermediate Similarity NPC135524
0.8271 Intermediate Similarity NPC17083
0.8271 Intermediate Similarity NPC205360
0.8258 Intermediate Similarity NPC25736
0.8258 Intermediate Similarity NPC57552
0.8258 Intermediate Similarity NPC276238
0.8254 Intermediate Similarity NPC184579
0.8254 Intermediate Similarity NPC233165
0.825 Intermediate Similarity NPC224584
0.8248 Intermediate Similarity NPC61590
0.8244 Intermediate Similarity NPC84672

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC96915 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9587 High Similarity NPD1470 Approved
0.9256 High Similarity NPD1201 Approved
0.8917 High Similarity NPD405 Clinical (unspecified phase)
0.8647 High Similarity NPD1509 Clinical (unspecified phase)
0.8175 Intermediate Similarity NPD5404 Approved
0.8175 Intermediate Similarity NPD5405 Approved
0.8175 Intermediate Similarity NPD5406 Approved
0.8175 Intermediate Similarity NPD5408 Approved
0.8116 Intermediate Similarity NPD2346 Discontinued
0.8 Intermediate Similarity NPD3226 Approved
0.7958 Intermediate Similarity NPD3300 Phase 2
0.7955 Intermediate Similarity NPD1164 Approved
0.7941 Intermediate Similarity NPD943 Approved
0.7914 Intermediate Similarity NPD2935 Discontinued
0.7902 Intermediate Similarity NPD7390 Discontinued
0.7794 Intermediate Similarity NPD2313 Discontinued
0.7769 Intermediate Similarity NPD3019 Approved
0.7724 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7714 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7664 Intermediate Similarity NPD3764 Approved
0.7661 Intermediate Similarity NPD9266 Approved
0.7661 Intermediate Similarity NPD74 Approved
0.7634 Intermediate Similarity NPD2932 Approved
0.763 Intermediate Similarity NPD2798 Approved
0.7589 Intermediate Similarity NPD3299 Clinical (unspecified phase)
0.7581 Intermediate Similarity NPD9263 Approved
0.7581 Intermediate Similarity NPD9264 Approved
0.7581 Intermediate Similarity NPD9267 Approved
0.7581 Intermediate Similarity NPD2342 Discontinued
0.7559 Intermediate Similarity NPD7635 Approved
0.7483 Intermediate Similarity NPD2344 Approved
0.7465 Intermediate Similarity NPD2799 Discontinued
0.7465 Intermediate Similarity NPD1510 Phase 2
0.7462 Intermediate Similarity NPD9493 Approved
0.7442 Intermediate Similarity NPD5951 Approved
0.7426 Intermediate Similarity NPD1203 Approved
0.7388 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7377 Intermediate Similarity NPD289 Clinical (unspecified phase)
0.7361 Intermediate Similarity NPD1471 Phase 3
0.7325 Intermediate Similarity NPD6232 Discontinued
0.7324 Intermediate Similarity NPD1607 Approved
0.7313 Intermediate Similarity NPD3026 Approved
0.7313 Intermediate Similarity NPD3023 Approved
0.7308 Intermediate Similarity NPD9281 Approved
0.7305 Intermediate Similarity NPD1240 Approved
0.7296 Intermediate Similarity NPD7473 Discontinued
0.7293 Intermediate Similarity NPD3025 Approved
0.7293 Intermediate Similarity NPD4196 Clinical (unspecified phase)
0.7293 Intermediate Similarity NPD3024 Approved
0.7279 Intermediate Similarity NPD2309 Approved
0.7258 Intermediate Similarity NPD9261 Approved
0.7211 Intermediate Similarity NPD3750 Approved
0.7211 Intermediate Similarity NPD7003 Approved
0.7206 Intermediate Similarity NPD4878 Approved
0.72 Intermediate Similarity NPD1237 Approved
0.7192 Intermediate Similarity NPD1549 Phase 2
0.7181 Intermediate Similarity NPD1511 Approved
0.7176 Intermediate Similarity NPD497 Approved
0.7171 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7133 Intermediate Similarity NPD447 Suspended
0.7133 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7131 Intermediate Similarity NPD288 Approved
0.7123 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7123 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7111 Intermediate Similarity NPD7163 Clinical (unspecified phase)
0.7101 Intermediate Similarity NPD1283 Approved
0.7101 Intermediate Similarity NPD1876 Approved
0.7099 Intermediate Similarity NPD495 Approved
0.7099 Intermediate Similarity NPD496 Approved
0.7099 Intermediate Similarity NPD498 Approved
0.7097 Intermediate Similarity NPD7819 Suspended
0.7097 Intermediate Similarity NPD2801 Approved
0.7086 Intermediate Similarity NPD1512 Approved
0.708 Intermediate Similarity NPD9717 Approved
0.7075 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.707 Intermediate Similarity NPD3749 Approved
0.7055 Intermediate Similarity NPD1551 Phase 2
0.7049 Intermediate Similarity NPD844 Approved
0.7044 Intermediate Similarity NPD6959 Discontinued
0.7042 Intermediate Similarity NPD411 Approved
0.704 Intermediate Similarity NPD1932 Approved
0.7037 Intermediate Similarity NPD1651 Approved
0.7032 Intermediate Similarity NPD6844 Discontinued
0.7031 Intermediate Similarity NPD9265 Clinical (unspecified phase)
0.702 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7013 Intermediate Similarity NPD4380 Phase 2
0.7007 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.6993 Remote Similarity NPD6663 Approved
0.6988 Remote Similarity NPD8312 Approved
0.6988 Remote Similarity NPD8313 Approved
0.6987 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6986 Remote Similarity NPD4308 Phase 3
0.6984 Remote Similarity NPD1929 Approved
0.6984 Remote Similarity NPD1931 Clinical (unspecified phase)
0.6984 Remote Similarity NPD1930 Approved
0.6982 Remote Similarity NPD8397 Clinical (unspecified phase)
0.698 Remote Similarity NPD8166 Discontinued
0.698 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6964 Remote Similarity NPD8150 Discontinued
0.695 Remote Similarity NPD5736 Approved
0.6947 Remote Similarity NPD1609 Clinical (unspecified phase)
0.6943 Remote Similarity NPD5402 Approved
0.6923 Remote Similarity NPD1934 Approved
0.6913 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6908 Remote Similarity NPD2532 Approved
0.6908 Remote Similarity NPD2534 Approved
0.6908 Remote Similarity NPD2533 Approved
0.6897 Remote Similarity NPD1899 Clinical (unspecified phase)
0.6884 Remote Similarity NPD1611 Approved
0.6884 Remote Similarity NPD1281 Approved
0.688 Remote Similarity NPD3020 Approved
0.6875 Remote Similarity NPD520 Approved
0.6871 Remote Similarity NPD3748 Approved
0.6867 Remote Similarity NPD5027 Approved
0.6867 Remote Similarity NPD5031 Approved
0.6867 Remote Similarity NPD5029 Approved
0.6863 Remote Similarity NPD6273 Approved
0.6861 Remote Similarity NPD2286 Discontinued
0.686 Remote Similarity NPD6214 Clinical (unspecified phase)
0.686 Remote Similarity NPD6212 Phase 3
0.686 Remote Similarity NPD6213 Phase 3
0.6853 Remote Similarity NPD5952 Clinical (unspecified phase)
0.6846 Remote Similarity NPD6831 Clinical (unspecified phase)
0.6839 Remote Similarity NPD7458 Discontinued
0.6838 Remote Similarity NPD3091 Approved
0.6835 Remote Similarity NPD1481 Phase 2
0.6835 Remote Similarity NPD9269 Phase 2
0.6835 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6835 Remote Similarity NPD3972 Approved
0.6826 Remote Similarity NPD5026 Approved
0.6826 Remote Similarity NPD4954 Approved
0.6826 Remote Similarity NPD5034 Approved
0.6826 Remote Similarity NPD5028 Approved
0.6826 Remote Similarity NPD36 Approved
0.6826 Remote Similarity NPD4955 Approved
0.6821 Remote Similarity NPD6534 Approved
0.6821 Remote Similarity NPD6535 Approved
0.6812 Remote Similarity NPD4879 Approved
0.6809 Remote Similarity NPD2797 Approved
0.6806 Remote Similarity NPD3268 Approved
0.6797 Remote Similarity NPD164 Approved
0.6794 Remote Similarity NPD3021 Approved
0.6794 Remote Similarity NPD3022 Approved
0.6792 Remote Similarity NPD7768 Phase 2
0.6788 Remote Similarity NPD5844 Phase 1
0.6788 Remote Similarity NPD9268 Approved
0.6786 Remote Similarity NPD1755 Approved
0.6783 Remote Similarity NPD6832 Phase 2
0.6774 Remote Similarity NPD2860 Approved
0.6774 Remote Similarity NPD2859 Approved
0.677 Remote Similarity NPD5494 Approved
0.6766 Remote Similarity NPD5030 Phase 2
0.6763 Remote Similarity NPD1535 Discovery
0.6752 Remote Similarity NPD7411 Suspended
0.6748 Remote Similarity NPD845 Approved
0.6748 Remote Similarity NPD1202 Approved
0.6739 Remote Similarity NPD4059 Approved
0.6739 Remote Similarity NPD4626 Approved
0.6736 Remote Similarity NPD7008 Discontinued
0.673 Remote Similarity NPD2296 Approved
0.673 Remote Similarity NPD8438 Clinical (unspecified phase)
0.6723 Remote Similarity NPD6780 Approved
0.6723 Remote Similarity NPD6782 Approved
0.6723 Remote Similarity NPD6778 Approved
0.6723 Remote Similarity NPD6776 Approved
0.6723 Remote Similarity NPD6781 Approved
0.6723 Remote Similarity NPD6777 Approved
0.6723 Remote Similarity NPD6779 Approved
0.6718 Remote Similarity NPD2329 Discontinued
0.6715 Remote Similarity NPD9545 Approved
0.6714 Remote Similarity NPD1608 Approved
0.6712 Remote Similarity NPD4307 Phase 2
0.6711 Remote Similarity NPD2796 Approved
0.6705 Remote Similarity NPD7700 Phase 2
0.6705 Remote Similarity NPD7699 Phase 2
0.6694 Remote Similarity NPD2934 Approved
0.6694 Remote Similarity NPD688 Clinical (unspecified phase)
0.6694 Remote Similarity NPD2933 Approved
0.669 Remote Similarity NPD3094 Phase 2
0.6689 Remote Similarity NPD2800 Approved
0.6687 Remote Similarity NPD3882 Suspended
0.6667 Remote Similarity NPD4093 Discontinued
0.6667 Remote Similarity NPD5037 Approved
0.6667 Remote Similarity NPD3600 Clinical (unspecified phase)
0.6667 Remote Similarity NPD5038 Approved
0.6667 Remote Similarity NPD1465 Phase 2
0.6667 Remote Similarity NPD4750 Phase 3
0.6667 Remote Similarity NPD6884 Clinical (unspecified phase)
0.6646 Remote Similarity NPD4381 Clinical (unspecified phase)
0.6646 Remote Similarity NPD7075 Discontinued
0.6645 Remote Similarity NPD1196 Approved
0.6645 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6643 Remote Similarity NPD3092 Approved
0.6639 Remote Similarity NPD9256 Approved
0.6639 Remote Similarity NPD9258 Approved
0.6627 Remote Similarity NPD3818 Discontinued
0.6627 Remote Similarity NPD3751 Discontinued
0.6623 Remote Similarity NPD1543 Discontinued
0.6619 Remote Similarity NPD3095 Discontinued

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data